Nanomedicine-small particles, big issues : A new regulatory dawn for health care law and bioethics?
In Michael D. A. Freeman (ed.), Law and Bioethics / Edited by Michael Freeman. Oxford University Press (2008)
|Abstract||This article has no associated abstract. (fix it)|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|External links||This entry has no external links. Add one.|
|Through your library||Configure|
Similar books and articles
Jessica Pierce (2002). Can Bioethics Survive in a Dying World? Journal of Medical Humanities 23 (1):3-6.
Roger Brownsword (2008). Regulating Nanomedicine—the Smallest of Our Concerns? NanoEthics 2 (1):73-86.
John Otieno Ouko (2009). Feminist Bioethics in the Global Scene: The Case of Kenya as a Developing Nation. International Journal of Feminist Approaches to Bioethics 2 (1):59 - 70.
Mark Henaghan (2011). Health Professionals and Trust: The Cure for Healthcare Law and Policy. Routledge-Cavendish.
Andrew Edgar (2013). The Dominance of Big Pharma: Power. [REVIEW] Medicine, Health Care and Philosophy 16 (2):295-304.
Micah L. Berman (2011). From Health Care Reform to Public Health Reform. Journal of Law, Medicine and Ethics 39 (3):328-339.
David C. Thomasma (2001). Personhood and Health Care. Kluwer Academic Pub..
Dan W. Brock (2000). Broadening the Bioethics Agenda. Kennedy Institute of Ethics Journal 10 (1):21-38.
Giorgia Guerra (2008). European Regulatory Issues in Nanomedicine. NanoEthics 2 (1):87-97.
Sorry, there are not enough data points to plot this chart.
Added to index2009-01-28
Recent downloads (6 months)0
How can I increase my downloads?